Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Johnson and Johnson
Covington
Merck
Federal Trade Commission
Healthtrust
Queensland Health
Chinese Patent Office
Cantor Fitzgerald
QuintilesIMS

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020412

« Back to Dashboard

NDA 020412 describes ZERIT, which is a drug marketed by Bristol Myers Squibb and is included in three NDAs. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the ZERIT profile page.

The generic ingredient in ZERIT is stavudine. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the stavudine profile page.
Summary for 020412
Tradename:ZERIT
Applicant:Bristol Myers Squibb
Ingredient:stavudine
Patents:0
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Pharmacology for NDA: 020412
Medical Subject Heading (MeSH) Categories for 020412
Suppliers and Packaging for NDA: 020412
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZERIT stavudine CAPSULE;ORAL 020412 NDA E.R. Squibb & Sons, L.L.C. 0003-1964 N 0003-1964-01
ZERIT stavudine CAPSULE;ORAL 020412 NDA E.R. Squibb & Sons, L.L.C. 0003-1965 N 0003-1965-01

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength5MG
Approval Date:Jun 24, 1994TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength15MG
Approval Date:Jun 24, 1994TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength20MG
Approval Date:Jun 24, 1994TE:ABRLD:Yes

Expired US Patents for NDA 020412

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb ZERIT stavudine CAPSULE;ORAL 020412-001 Jun 24, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb ZERIT stavudine CAPSULE;ORAL 020412-004 Jun 24, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb ZERIT stavudine CAPSULE;ORAL 020412-005 Jun 24, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb ZERIT stavudine CAPSULE;ORAL 020412-002 Jun 24, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Bristol Myers Squibb ZERIT stavudine CAPSULE;ORAL 020412-003 Jun 24, 1994 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Boehringer Ingelheim
Colorcon
Mallinckrodt
McKesson
Healthtrust
Moodys
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot